Bethyl Laboratories will be closed on July 3, 2020, in observance of the Independence Day holiday. We re-open on July 6, 2020.

You are what (and when) you eat

Contributed by Jane Naberhuis, Ph.D.


Humans and animals typically consume nutrients in a feeding-fasting cycle. For example, in the typical breakfast-lunch-dinner daily eating pattern, consumption of a meal is usually followed by at least several hours of fasting. This feeding-fasting cycle means that organisms must be able to cope with large shifts in concentrations of nutrients such as glucose, amino acids, and lipids within the blood. The blood levels of these nutrients reach a peak shortly after a meal, and may become very low during fasting. Maintenance of homeostasis during the feeding-fasting cycle requires careful coordination of gene regulation to optimize metabolic efficiency. If gene regulation is disturbed or timed incorrectly, the resulting metabolic dysfunction can lead to development of diseases such as obesity and diabetes.1 Thus, it seems as though not only what an organism eats, but also when that organism eats, is important for maintaining metabolic health.


Control of gene expression requires factors that facilitate interactions between DNA, RNA, and protein. The Drosophila behavior/human splicing (DBHS) family of proteins mediate various protein-protein and protein-nucleic acid interactions, and influence gene expression in pathways as diverse as those relevant to neurobiology,2 development,3 innate immunity,4 cancer,5 and DNA repair.6


One member of the DBHS family of proteins, non-POU domain-containing octamer-binding protein (NONO), is emerging as central to the link between feeding and metabolism. In mice, NONO binds to pre-mRNA of genes involved in hepatic glucose and lipid metabolism, and post-transcriptionally regulates the rhythmic expression of these genes in response to the presence of nutrients.7 Using immunoprecipitation and immunostaining techniques, the number of target RNAs bound by NONO, as well as the number of NONO positive foci, were found to increase in hepatic cell nuclei of mice upon feeding.7 NONO was also identified as a component of paraspeckles, sub-nuclear bodies that regulate gene expression by retaining RNA in the nucleus.7 Furthermore, a large proportion of NONO-bound RNAs encode proteins involved in macronutrient metabolism and glucose uptake. In NONO-deficient mice, the rhythmic pattern of gene expression in response to nutrient availability is disrupted, resulting in reduced glucose tolerance as well as glycogen and lipid storage capabilities.7


These recent findings suggest that NONO post-transcriptionally coordinates RNA expression of genes involved in nutrient metabolism in response to nutritional stimuli. Identification of NONO as a novel player involved in the maintenance of metabolic homeostasis during the feeding-fasting cycle also suggests that you are not only what you eat, but also when you eat it!


Bethyl offers the following NONO antibodies: NONO, NONO, NONO AbVantage™ Pack, NONO IHC



Did you like this article?

Be sure to join Bethyl’s mailing list to receive limited-time promotions, new product information, and more articles like this one.

Join Mailing List
Detection of human NONO in FFPE prostate carcinoma.

Detection of human NONO in FFPE prostate carcinoma. Antibody: Rabbit anti-NONO (A300-582A). Secondary: HRP-conjugated goat anti-rabbit IgG (A120-501P). Substrate: DAB.

Detection of human and mouse NONO in FFPE breast carcinoma (left) and mouse squamous cell carcinoma (right) by IHC.

Detection of human and mouse NONO in FFPE breast carcinoma (left) and mouse squamous cell carcinoma (right) by IHC. Antibody: Rabbit anti-NONO (A300-587A).  Secondary: HRP-conjugated goat anti-rabbit IgG (A120-501P). Substrate: DAB.


1. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. 2009. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. Mar;106(11):4453-4458.

2. Mircsof D, Langouet M, Rio M, Moutton S, Siquier-Pernet K, Bole-Feysot C, et al. 2015. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects. Nat Neurosci. Dec;18(12):1731-1736.

3. Yadav SP, Hao H, Yang HJ, Kautzmann MA, Brooks M, Nellissery J, et al. 2014. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression. Hum Mol Genet. Apr;23(8):2132-2144.

4. Gelais CS, Roger J, Wu L. 2015. Non-POU domain-containing octamer-binding protein negatively regulates HIV-1 infection in CD4(+) T cells. Aids Res Hum Retrov. Aug;31(8):806-816.

5. Schiffner S, Zimara N, Schmid R, Bosserhoff AK. 2011. p54nrb is a new regulator of progression of malignant melanoma. Carcinogenesis. Aug;32(8):1176-1182.

6. Knott GJ, Bond CS, Fox AH. 2016. The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. May;44(9):3989-4004.

7. Benegiamo G, Mure LS, Erikson G, Le HD, Moriggi E, Brown SA, et al. 2018. The RNA-binding protein NONO coordinates hepatic adaptation to feeding. Cell Metab. Feb;27(2):404-418.e7.